$DHC
Diversified Healthcare Trust Stock $dhc

$dhc Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000107541523000017 Filed on May 08, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$346.2M	$346.0M
YoY Change	10.6%	11.36%
Cost Of Revenue	$286.2M	$286.1M
YoY Change	7.58%	6.45%
Gross Profit	$59.99M	$59.95M
YoY Change	27.74%	42.77%
Gross Profit Margin	17.33%	17.33%
Selling, General & Admin	$7.284M	$5.873M
YoY Change	1.07%	-19.38%
% of Gross Profit	12.14%	9.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$68.39M	$64.80M
YoY Change	17.39%	13.17%
% of Gross Profit	114.01%	108.09%
Operating Expenses	$75.68M	$70.67M
YoY Change	15.6%	9.5%
Operating Profit	-$15.69M	-$10.72M
YoY Change	-15.23%	-52.45%
Interest Expense	-$42.25M	$47.78M
YoY Change	-175.48%	-16.37%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$75.28M	-$52.04M
YoY Change	-33.51%	-121.82%
Income Tax	$221.0K	-$31.00K
% Of Pretax Income
Net Earnings	-$72.57M	-$52.66M
YoY Change	-33.65%	-121.9%
Net Earnings / Revenue	-20.96%	-15.22%
Basic Earnings Per Share	-$0.30	-$0.22
Diluted Earnings Per Share	-$0.30	-$0.22
COMMON SHARES
Basic Shares Outstanding	239.7M shares	239.7M shares
Diluted Shares Outstanding	238.7M shares	238.6M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$338.4M	$380.1M
YoY Change	-52.01%	-48.08%
Cash & Equivalents	$338.4M	$380.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$338.4M	$380.1M
YoY Change	-52.01%	-48.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.829B	$4.870B
YoY Change	1.4%	2.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$155.1M	$153.4M
YoY Change	-2.29%	-42.48%
Other Assets	$40.68M	$2.552M
YoY Change	-75.08%	-99.66%
Total Long-Term Assets	$5.247B	$5.287B
YoY Change	-3.56%	-12.52%
TOTAL ASSETS
Total Short-Term Assets	$338.4M	$380.1M
Total Long-Term Assets	$5.247B	$5.287B
Total Assets	$5.585B	$5.667B
YoY Change	-9.12%	-16.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$53.55M	$58.07M
YoY Change	-4.42%	-22.22%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$53.55M	$58.07M
YoY Change	-4.42%	-22.22%
LONG-TERM LIABILITIES
Long-Term Debt	$2.785B	$2.798B
YoY Change	-9.37%	-21.77%
Other Long-Term Liabilities	$238.0M	$226.4M
YoY Change	4.44%	1.6%
Total Long-Term Liabilities	$3.023B	$3.025B
YoY Change	-8.41%	-20.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$53.55M	$58.07M
Total Long-Term Liabilities	$3.023B	$3.025B
Total Liabilities	$3.076B	$3.083B
YoY Change	-8.35%	-20.43%
SHAREHOLDERS EQUITY
Retained Earnings	$1.947B	$2.019B
YoY Change	-12.26%	-13.27%
Common Stock	$4.620B	$4.620B
YoY Change	0.03%	0.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.509B	$2.584B
YoY Change
Total Liabilities & Shareholders Equity	$5.585B	$5.667B
YoY Change	-9.12%	-16.36%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$72.57M	-$52.66M
YoY Change	-33.65%	-121.9%
Depreciation, Depletion And Amortization	$68.39M	$64.80M
YoY Change	17.39%	13.17%
Cash From Operating Activities	$25.68M	$6.042M
YoY Change	-204.43%	-183.18%
INVESTING ACTIVITIES
Capital Expenditures	$47.64M	$60.29M
YoY Change	-178.3%	-208.07%
Acquisitions
YoY Change
Other Investing Activities	$14.01M	$3.548M
YoY Change	6569.52%	-99.45%
Cash From Investing Activities	-$33.64M	-$56.74M
YoY Change	-44.53%	-109.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-17.63M	-$254.9M
YoY Change	-96.73%	140.41%
NET CHANGE
Cash From Operating Activities	25.68M	$6.042M
Cash From Investing Activities	-33.64M	-$56.74M
Cash From Financing Activities	-17.63M	-$254.9M
Net Change In Cash	-25.59M	-$305.6M
YoY Change	-95.9%	-164.34%
FREE CASH FLOW
Cash From Operating Activities	$25.68M	$6.042M
Capital Expenditures	$47.64M	$60.29M
Free Cash Flow	-$21.96M	-$54.25M
YoY Change	-160.57%	-211.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001075415
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-15319
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	DIVERSIFIED HEALTHCARE TRUST
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3445278
CY2022Q4	us-gaap	Land Land	668918000	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6056766000	usd
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Two Newton Place, 255 Washington Street, Suite 300,
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Newton
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02458-1634
CY2023Q1	dei	City Area Code CityAreaCode	617
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	796 - 8350
CY2023Q1	dei	Security12b Title Security12bTitle	Common Shares of Beneficial Interest
CY2023Q1	dei	Trading Symbol TradingSymbol	DHC
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	239682467	shares
CY2023Q1	us-gaap	Land Land	666797000	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	6023625000	usd
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	6723563000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	6692543000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1878997000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1828352000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4844566000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4864191000	usd
CY2023Q1	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	153419000	usd
CY2022Q4	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	155477000	usd
CY2023Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	0	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group AssetsHeldForSaleNotPartOfDisposalGroup	385000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	380117000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	658065000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	2552000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	30237000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	42045000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45351000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	244031000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	248387000	usd
CY2023Q1	us-gaap	Assets Assets	5666730000	usd
CY2022Q4	us-gaap	Assets Assets	6002093000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	450000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	700000000	usd
CY2023Q1	us-gaap	Senior Notes SeniorNotes	2318907000	usd
CY2022Q4	us-gaap	Senior Notes SeniorNotes	2317700000	usd
CY2023Q1	dhc	Secured Debt And Finance Lease Obligations SecuredDebtAndFinanceLeaseObligations	29574000	usd
CY2022Q4	dhc	Secured Debt And Finance Lease Obligations SecuredDebtAndFinanceLeaseObligations	30177000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	31957000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	29417000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	252473000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	286188000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3082911000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3363482000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	239682467	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	239682467	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	239694842	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	239694842	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	2397000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2397000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4617294000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4617031000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2019192000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2071850000	usd
CY2023Q1	dhc	Cumulative Common Stock Dividends CumulativeCommonStockDividends	4055064000	usd
CY2022Q4	dhc	Cumulative Common Stock Dividends CumulativeCommonStockDividends	4052667000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2583819000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2638611000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5666730000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6002093000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	346030000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	310733000	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	286080000	usd
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	268742000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	64800000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	57259000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5873000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7285000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	93000	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	928000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5925000	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	362771000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	334214000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1233000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	327794000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	8126000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-8553000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	4195000	usd
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	395000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2074000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2472000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	47780000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	57131000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1075000	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-483000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-52042000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	238541000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1472000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-52658000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	240423000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	238589000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	238149000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	238589000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	238198000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.01
CY2023Q1	us-gaap	Depreciation Depreciation	64800000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	57259000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2638611000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-52658000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2397000	usd
CY2023Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	270000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	1000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2583819000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2662390000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	240423000	usd
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	2390000	usd
CY2022Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	318000	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	3000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2900733000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-52658000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	240423000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2074000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2472000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	2448000	usd
CY2022Q1	us-gaap	Straight Line Rent StraightLineRent	1745000	usd
CY2023Q1	dhc	Amortization Of Acquired Real Estate Leases And Other Intangible Assets AmortizationOfAcquiredRealEstateLeasesAndOtherIntangibleAssets	-311000	usd
CY2022Q1	dhc	Amortization Of Acquired Real Estate Leases And Other Intangible Assets AmortizationOfAcquiredRealEstateLeasesAndOtherIntangibleAssets	105000	usd
CY2023Q1	dhc	Gain Loss On Early Extinguishment Of Debt GainLossOnEarlyExtinguishmentOfDebt	-1075000	usd
CY2022Q1	dhc	Gain Loss On Early Extinguishment Of Debt GainLossOnEarlyExtinguishmentOfDebt	-483000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5925000	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1233000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	327794000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	8126000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-8553000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	674000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	628000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1411000	usd
CY2022Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2720000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-647000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3354000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	1954000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Leasing Fees IncreaseDecreaseInDeferredLeasingFees	2568000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-15499000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-21326000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2540000	usd
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	15734000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-20525000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-20250000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6042000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7264000	usd
CY2023Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	60292000	usd
CY2022Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	55791000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	3548000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	252000	usd
CY2023Q1	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	0	usd
CY2022Q1	us-gaap	Proceeds From Real Estate And Real Estate Joint Ventures ProceedsFromRealEstateAndRealEstateJointVentures	643892000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56744000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	588353000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	250000000	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	100000000	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	538000	usd
CY2022Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	838000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1990000	usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2805000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2397000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2390000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-254931000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-106038000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-305633000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	475051000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	688302000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1016945000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382669000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1491996000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	43166000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	38925000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	50000	usd
CY2023Q1	dhc	Receivable From Tender Offer ReceivableFromTenderOffer	14006000	usd
CY2022Q1	dhc	Receivable From Tender Offer ReceivableFromTenderOffer	0	usd
CY2023Q1	dhc	Deconsolidation Of Previously Consolidated Investments Real Estate DeconsolidationOfPreviouslyConsolidatedInvestmentsRealEstate	0	usd
CY2022Q1	dhc	Deconsolidation Of Previously Consolidated Investments Real Estate DeconsolidationOfPreviouslyConsolidatedInvestmentsRealEstate	355669000	usd
CY2023Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	20195000	usd
CY2022Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	20645000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	380117000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	732058000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	2552000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	759938000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382669000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1491996000	usd
CY2023Q1	dhc	Consolidated Income Available To Debt Ratio ConsolidatedIncomeAvailableToDebtRatio	1.5
CY2023Q1	dhc	Consolidated Income Available To Debt Ratio ConsolidatedIncomeAvailableToDebtRatio	1.5
CY2023Q1	dhc	Consolidated Income Available To Debt Ratio ConsolidatedIncomeAvailableToDebtRatio	1.5
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	380117000	usd
CY2023Q1	us-gaap	Debt Current DebtCurrent	700000000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	450000000	usd
CY2023Q1	dhc	Encumbered Properties Appraised Value EncumberedPropertiesAppraisedValue	1300000000	usd
CY2023Q1	us-gaap	Senior Notes Current SeniorNotesCurrent	250000000	usd
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	376	property
CY2023Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	36	state
CY2023Q1	dhc	Number Of States NumberOfStates	5	state
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	2448000	usd
CY2022Q1	us-gaap	Straight Line Rent StraightLineRent	1745000	usd
CY2023Q1	dhc	Straight Line Rent Excluding Properties Heldfor Sale StraightLineRentExcludingPropertiesHeldforSale	78811000	usd
CY2022Q4	dhc	Straight Line Rent Excluding Properties Heldfor Sale StraightLineRentExcludingPropertiesHeldforSale	76363000	usd
CY2023Q1	us-gaap	Variable Lease Payment VariableLeasePayment	11986000	usd
CY2022Q1	us-gaap	Variable Lease Payment VariableLeasePayment	10708000	usd
CY2023Q1	dhc	Reimbursement Revenue Lease ReimbursementRevenueLease	11924000	usd
CY2022Q1	dhc	Reimbursement Revenue Lease ReimbursementRevenueLease	10663000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25729000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	26110000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26508000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	26889000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	338000	usd
CY2023Q1	dhc	Consolidated Income Available To Debt Ratio ConsolidatedIncomeAvailableToDebtRatio	1.5
CY2023Q1	dhc	Consolidated Income Available To Debt Ratio ConsolidatedIncomeAvailableToDebtRatio	1.5
CY2023Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	8126000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-8553000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.01
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2397000	usd
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	346030000	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	286080000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	64800000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5873000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	93000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5925000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	362771000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1233000	usd
CY2022Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-8553000	usd
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	395000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	8126000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	4195000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	47780000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1075000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-52042000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-647000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-52658000	usd
CY2023Q1	us-gaap	Assets Assets	5666730000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	310733000	usd
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	268742000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	57259000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7285000	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	928000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	334214000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	327794000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	57131000	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-483000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	238541000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1472000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3354000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	240423000	usd
CY2022Q4	us-gaap	Assets Assets	6002093000	usd
CY2023Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	0	employee
CY2023Q1	dhc	Property Management And Construction Supervision Fees PropertyManagementAndConstructionSupervisionFees	1992000	usd
CY2022Q1	dhc	Property Management And Construction Supervision Fees PropertyManagementAndConstructionSupervisionFees	2391000	usd
CY2023Q1	dhc	Property Management And Construction Supervision Fees Paid PropertyManagementAndConstructionSupervisionFeesPaid	3533000	usd
CY2022Q1	dhc	Property Management And Construction Supervision Fees Paid PropertyManagementAndConstructionSupervisionFeesPaid	2964000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1472000	usd

Files In Submission

Name	View Source	Status
0001075415-23-000017-index-headers.html	Edgar Link	pending
0001075415-23-000017-index.html	Edgar Link	pending
0001075415-23-000017.txt	Edgar Link	pending
0001075415-23-000017-xbrl.zip	Edgar Link	pending
dhc-20230331.htm	Edgar Link	pending
dhc-20230331.xsd	Edgar Link	pending
dhc_033123xexhibitx311.htm	Edgar Link	pending
dhc_033123xexhibitx312.htm	Edgar Link	pending
dhc_033123xexhibitx321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
dhc-20230331_cal.xml	Edgar Link	unprocessable
dhc-20230331_def.xml	Edgar Link	unprocessable
dhc-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
dhc-20230331_pre.xml	Edgar Link	unprocessable
dhc-20230331_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DHC
Diversified Healthcare Trust Stock $dhc

2023 Q2 Form 10-Q Financial Statement

#000107541523000017 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DHC Diversified Healthcare Trust Stock $dhc

2023 Q2 Form 10-Q Financial Statement

#000107541523000017 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DHC
Diversified Healthcare Trust Stock $dhc